StonvexLoading…
StonvexStonvexStonvexCore line items from FTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | C$11.90B | C$11.24B | C$11.16B | C$10.91B |
Operating Income | C$3.49B | C$3.29B | C$3.08B | C$2.74B |
Net Income | C$1.96B | C$1.83B | C$1.71B | C$1.51B |
EPS (Diluted) | C$3.40 | C$3.24 | C$3.10 | C$2.78 |
Total Assets | C$74.83B | C$73.49B | C$65.92B | C$64.25B |
Total Liabilities | C$48.96B | C$47.63B | C$42.59B | C$41.41B |
Cash & Equivalents | C$367.00M | C$220.00M | C$625.00M | C$209.00M |
Free Cash Flow OCF − CapEx | C$-1.88B | C$-1.13B | C$-441.00M | C$-513.00M |
Shares Outstanding | 507.30M | 499.30M | 490.60M | 482.20M |